Javascript must be enabled to continue!
Central Asian Rodents as Model Animals for Leishmania major and Leishmania donovani Research
View through CrossRef
The clinical manifestation of leishmaniases depends on parasite species, host genetic background, and immune response. Manifestations of human leishmaniases are highly variable, ranging from self-healing skin lesions to fatal visceral disease. The scope of standard model hosts is insufficient to mimic well the wide disease spectrum, which compels the introduction of new model animals for leishmaniasis research. In this article, we study the susceptibility of three Asian rodent species (Cricetulus griseus, Lagurus lagurus, and Phodopus sungorus) to Leishmania major and L. donovani. The external manifestation of the disease, distribution, as well as load of parasites and infectiousness to natural sand fly vectors, were compared with standard models, BALB/c mice and Mesocricetus auratus. No significant differences were found in disease outcomes in animals inoculated with sand fly- or culture-derived parasites. All Asian rodent species were highly susceptible to L. major. Phodopus sungorus showed the non-healing phenotype with the progressive growth of ulcerative lesions and massive parasite loads. Lagurus lagurus and C. griseus represented the healing phenotype, the latter with high infectiousness to vectors, mimicking best the character of natural reservoir hosts. Both, L. lagurus and C. griseus were also highly susceptible to L. donovani, having wider parasite distribution and higher parasite loads and infectiousness than standard model animals.
Title: Central Asian Rodents as Model Animals for Leishmania major and Leishmania donovani Research
Description:
The clinical manifestation of leishmaniases depends on parasite species, host genetic background, and immune response.
Manifestations of human leishmaniases are highly variable, ranging from self-healing skin lesions to fatal visceral disease.
The scope of standard model hosts is insufficient to mimic well the wide disease spectrum, which compels the introduction of new model animals for leishmaniasis research.
In this article, we study the susceptibility of three Asian rodent species (Cricetulus griseus, Lagurus lagurus, and Phodopus sungorus) to Leishmania major and L.
donovani.
The external manifestation of the disease, distribution, as well as load of parasites and infectiousness to natural sand fly vectors, were compared with standard models, BALB/c mice and Mesocricetus auratus.
No significant differences were found in disease outcomes in animals inoculated with sand fly- or culture-derived parasites.
All Asian rodent species were highly susceptible to L.
major.
Phodopus sungorus showed the non-healing phenotype with the progressive growth of ulcerative lesions and massive parasite loads.
Lagurus lagurus and C.
griseus represented the healing phenotype, the latter with high infectiousness to vectors, mimicking best the character of natural reservoir hosts.
Both, L.
lagurus and C.
griseus were also highly susceptible to L.
donovani, having wider parasite distribution and higher parasite loads and infectiousness than standard model animals.
Related Results
Leishmania
parasite arginine deprivation response pathway influences the host macrophage lysosomal arginine sensing machinery
Leishmania
parasite arginine deprivation response pathway influences the host macrophage lysosomal arginine sensing machinery
Abstract
Extensive interaction between the host and pathogen metabolic networks decidedly shapes the outcome of infection. Infection with
...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Livestock infected with Leishmania spp. in southern Iran
Livestock infected with Leishmania spp. in southern Iran
Abstract
Background
The magnitude of the health problems caused by leishmaniasis has been a major driving factor behind the development and implemen...
Sergentomyia schwetzi is not a competent vector for Leishmania donovani and other Leishmania species pathogenic to humans
Sergentomyia schwetzi is not a competent vector for Leishmania donovani and other Leishmania species pathogenic to humans
Abstract
Background
Sand fly species of the genus Sergentomyia are proven vectors of reptilian Leishmania that are non-pathogenic to humans. Howe...
First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia
First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia
Abstract
Background
Leishmaniasis is a common neglected tropical disease in Ethiopia. Visceral lei...
Prevalence of Leishmania donovani Infection in Humans and Dogs in Gadarif State, Sudan: A Diagnostic Comparison
Prevalence of Leishmania donovani Infection in Humans and Dogs in Gadarif State, Sudan: A Diagnostic Comparison
Background: Leishmania donovani is a protozoan parasite that causes visceral leishmaniasis, a potentially fatal disease in humans and dogs. The epidemiology and transmission dynami...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...

